Uncontrolled Fluid Intake Remained a Variable in the Urinary CBD Study
Participants did not consume a controlled amount of fluid in the urinary CBD study. The investigators therefore could not eliminate between-person dilution differences when interpreting urine concentrations.
A controlled dose did not control every input
The experiment assigned cannabinoid dosing conditions and collected urine for an extended period on a research unit. Yet the authors explicitly identified fluid intake as uncontrolled. They measured creatinine, but collecting that measurement is not equivalent to making every participant produce urine of identical dilution.
Concentration and excreted amount differ
A urine concentration expresses analyte relative to specimen volume. The study also used measured collection volumes to calculate excreted amounts. These outputs answer different questions, and a concentration difference should not automatically be described as a difference in administered dose or total body exposure. Dilution is one possible contributor, not a complete explanation for every observed difference.
The tradeoff should remain explicit
The authors considered the variation potentially representative of real-world drug-testing conditions. That practical relevance does not turn the concentrations into a hydration-independent biological marker. When comparing an individual result with this research, retain collection interval, volume, analyte and any normalization procedure. Neither an unadjusted urine value nor creatinine alone establishes functional impairment.
Related analysis: the urinary CBD route comparison.
Research cited
Sholler and colleagues (2021). Urinary Pharmacokinetic Profile of Cannabidiol, THC and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration. DOI: 10.1093/jat/bkab059.
